Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
Clinical trial NCT06311942 · RECRUITING
Trial details
- NCT number
- NCT06311942
- Sponsor
- Chen Xiaoping
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2027-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.